Search Results - "GADALETA, Cosmo"

Refine Results
  1. 1

    Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma by Marech, Ilaria, Gadaleta, Cosmo Damiano, Ranieri, Girolamo

    “…Renal cell carcinoma (RCC) is the most frequent renal tumor and its incidence is increasing worldwide. Tumor angiogenesis is known to play a crucial role in…”
    Get full text
    Journal Article
  2. 2

    PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review) by Loizzi, Vera, Ranieri, Girolamo, Laforgia, Mariarita, Gadaleta, Cosmo Damiano, Gargano, Giulio, Kardhashi, Anila, Liso, Maria De, Naglieri, Emanuele, Vecchio, Vittoria Del, Cicinelli, Ettore, Cormio, Gennaro

    Published in Oncology letters (01-10-2020)
    “…Epithelial ovarian cancer (EOC) has a poor prognosis. Since the introduction of paclitaxel as antineoplastic agent >20 years ago, only a few phase III…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Peripheral Neuropathy under Oncologic Therapies: A Literature Review on Pathogenetic Mechanisms by Laforgia, Mariarita, Laface, Carmelo, Calabrò, Concetta, Ferraiuolo, Simona, Ungaro, Valentina, Tricarico, Domenico, Gadaleta, Cosmo Damiano, Nardulli, Patrizia, Ranieri, Girolamo

    “…Peripheral neurologic complications are frequent adverse events during oncologic treatments and often lead to dose reduction, administration delays with time…”
    Get full text
    Journal Article
  11. 11

    Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review by Laface, Carmelo, Laforgia, Mariarita, Molinari, Pasquale, Foti, Caterina, Ambrogio, Francesca, Gadaleta, Cosmo Damiano, Ranieri, Girolamo

    Published in Cancers (17-01-2022)
    “…Advanced pancreatic cancer (PC) has a very poor prognosis due to its chemoresistant nature. Nowadays, only a few therapeutic options are available for PC, and…”
    Get full text
    Journal Article
  12. 12

    Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatobiliary Cancers: State of the Art by Laface, Carmelo, Laforgia, Mariarita, Molinari, Pasquale, Ugenti, Ippazio, Gadaleta, Cosmo Damiano, Porta, Camillo, Ranieri, Girolamo

    Published in Cancers (21-06-2021)
    “…Liver functional failure is one of the leading causes of cancer-related death. Primary liver tumors grow up mainly in the liver, and thus happens for liver…”
    Get full text
    Journal Article
  13. 13

    Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients by RANIERI, Girolamo, AMMENDOLA, Michele, RIBATTI, Domenico, PATRUNO, Rosa, CELANO, Giuseppe, ALFREDO ZITO, Francesco, MONTEMURRO, Severino, RELLA, Addolorata, DI LECCE, Valentina, DAMIANO GADALETA, Cosmo, BATTISTA DE SARRO, Giovanni

    Published in International journal of oncology (01-07-2009)
    “…Literature data indicate that mast cells (MCs) are involved in tumor angiogenesis due to the release of several pro-angiogenetic factors among which tryptase,…”
    Get full text
    Journal Article
  14. 14

    Restoring TRAIL Induced Apoptosis Using Naturopathy. Hercules Joins Hand with Nature to Triumph Over Lernaean Hydra by Farooqi, Ammad Ahmad, Gadaleta, Cosmo Damiano, Ranieri, Girolamo, Fayyaz, Sundas, Marech, Ilaria

    Published in Current genomics (01-02-2017)
    “…Cancer is a multifaceted disease. Our deepened knowledge about genetic and biological mechanisms of cancer cells presents an opportunity to explore the…”
    Get full text
    Journal Article
  15. 15

    Oxaliplatin-Based Intra-arterial Chemotherapy in Colo-Rectal Cancer Liver Metastases: A Review from Pharmacology to Clinical Application by Ranieri, Girolamo, Laforgia, Mariarita, Nardulli, Patrizia, Ferraiuolo, Simona, Molinari, Pasquale, Marech, Ilaria, Gadaleta, Cosmo Damiano

    Published in Cancers (24-01-2019)
    “…Liver metastases (LM) are often consequences of colo-rectal cancer (CRC)and the majority of patients have unresectable LM. Oxaliplatin-based intravenous…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Masitinib (AB1010), from canine tumor model to human clinical development: Where we are? by Marech, Ilaria, Patruno, Rosa, Zizzo, Nicola, Gadaleta, Claudia, Introna, Marcello, Zito, Alfredo Francesco, Gadaleta, Cosmo Damiano, Ranieri, Girolamo

    Published in Critical reviews in oncology/hematology (01-07-2014)
    “…Abstract Masitinib mesylate (AB1010) is a novel potent and selective tyrosine kinase inhibitor, targeting mainly wild-type and mutated c-Kit receptor (c-KitR),…”
    Get full text
    Journal Article
  18. 18

    Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients by Ranieri, Girolamo, Ammendola, Michele, Marech, Ilaria, Laterza, Annamaria, Abbate, Ines, Oakley, Caroline, Vacca, Angelo, Sacco, Rosario, Gadaleta, Cosmo Damiano

    Published in World journal of gastroenterology : WJG (21-05-2015)
    “…To evaluate vascular endothelial growth factor (VEGF) and tryptase in hepatocellular cancer (HCC) before and after trans-arterial chemoembolization (TACE)…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Possible biological and translational significance of mast cells density in colorectal cancer by Marech, Ilaria, Ammendola, Michele, Gadaleta, Claudia, Zizzo, Nicola, Oakley, Caroline, Gadaleta, Cosmo Damiano, Ranieri, Girolamo

    Published in World journal of gastroenterology : WJG (21-07-2014)
    “…Mast cells(MCs), located ubiquitously near blood vessels, are descended from CD34+ hematopoietic stem cells. Initially, although their role has been well…”
    Get full text
    Journal Article